hrs4800
Small moleculeexperimental
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 30, 2020 (NCT04573036)
Timeline
Indications
Studied for
Mechanism of action
SCN10A inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05318846 | Phase 2 | Jan 14, 2022 | Hengrui Therapeutics, Inc. |
| NCT04991909 | Phase 1 | Aug 23, 2021 | Hengrui Therapeutics, Inc. |
| NCT04862884 | Phase 1 | May 3, 2021 | Hengrui Therapeutics, Inc. |
| NCT04573036 | Phase 1 | Nov 30, 2020 | Atridia Pty Ltd. |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hengrui Therapeutics, Inc. | For profit | 3 | 3 | 2 | 2021 |
| Atridia Pty Ltd. | For profit | 1 | 1 | 1 | 2020 |
2 organizations
Page 1 / 1